4//SEC Filing
Lowenthal Richard E 4
Accession 0001415889-25-000464
CIK 0001671858other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:30 PM ET
Size
7.6 KB
Accession
0001415889-25-000464
Insider Transaction Report
Form 4
Lowenthal Richard E
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Award
Stock option (right to buy)
2025-01-02+767,600→ 767,600 totalExercise: $10.71Exp: 2035-01-01→ Common Stock (767,600 underlying) - Award
Stock Option (right to buy)
2025-01-02+261,900→ 261,900 total(indirect: By Spouse)Exercise: $10.71Exp: 2035-01-01→ Common Stock (261,900 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001378550
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:30 PM ET
- Size
- 7.6 KB